1-22081699-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001791.4(CDC42):c.106-23G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0051 in 1,484,692 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0037 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0053 ( 35 hom. )
Consequence
CDC42
NM_001791.4 intron
NM_001791.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.564
Publications
3 publications found
Genes affected
CDC42 (HGNC:1736): (cell division cycle 42) The protein encoded by this gene is a small GTPase of the Rho-subfamily, which regulates signaling pathways that control diverse cellular functions including cell morphology, migration, endocytosis and cell cycle progression. This protein is highly similar to Saccharomyces cerevisiae Cdc 42, and is able to complement the yeast cdc42-1 mutant. The product of oncogene Dbl was reported to specifically catalyze the dissociation of GDP from this protein. This protein could regulate actin polymerization through its direct binding to Neural Wiskott-Aldrich syndrome protein (N-WASP), which subsequently activates Arp2/3 complex. Alternative splicing of this gene results in multiple transcript variants. Pseudogenes of this gene have been identified on chromosomes 3, 4, 5, 7, 8 and 20. [provided by RefSeq, Apr 2013]
CDC42 Gene-Disease associations (from GenCC):
- macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BS2
High AC in GnomAd4 at 562 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDC42 | NM_001791.4 | c.106-23G>T | intron_variant | Intron 2 of 5 | ENST00000656825.1 | NP_001782.1 | ||
| CDC42 | NM_001039802.2 | c.106-23G>T | intron_variant | Intron 3 of 6 | NP_001034891.1 | |||
| CDC42 | NM_044472.3 | c.106-23G>T | intron_variant | Intron 2 of 5 | NP_426359.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00369 AC: 561AN: 152190Hom.: 4 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
561
AN:
152190
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00382 AC: 953AN: 249384 AF XY: 0.00392 show subpopulations
GnomAD2 exomes
AF:
AC:
953
AN:
249384
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00526 AC: 7015AN: 1332384Hom.: 35 Cov.: 20 AF XY: 0.00529 AC XY: 3546AN XY: 669734 show subpopulations
GnomAD4 exome
AF:
AC:
7015
AN:
1332384
Hom.:
Cov.:
20
AF XY:
AC XY:
3546
AN XY:
669734
show subpopulations
African (AFR)
AF:
AC:
18
AN:
30928
American (AMR)
AF:
AC:
49
AN:
44308
Ashkenazi Jewish (ASJ)
AF:
AC:
32
AN:
25306
East Asian (EAS)
AF:
AC:
1
AN:
39096
South Asian (SAS)
AF:
AC:
156
AN:
83346
European-Finnish (FIN)
AF:
AC:
181
AN:
52828
Middle Eastern (MID)
AF:
AC:
5
AN:
5512
European-Non Finnish (NFE)
AF:
AC:
6370
AN:
995076
Other (OTH)
AF:
AC:
203
AN:
55984
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
317
634
951
1268
1585
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
222
444
666
888
1110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00369 AC: 562AN: 152308Hom.: 4 Cov.: 33 AF XY: 0.00353 AC XY: 263AN XY: 74462 show subpopulations
GnomAD4 genome
AF:
AC:
562
AN:
152308
Hom.:
Cov.:
33
AF XY:
AC XY:
263
AN XY:
74462
show subpopulations
African (AFR)
AF:
AC:
36
AN:
41578
American (AMR)
AF:
AC:
14
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5188
South Asian (SAS)
AF:
AC:
6
AN:
4830
European-Finnish (FIN)
AF:
AC:
22
AN:
10600
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
474
AN:
68026
Other (OTH)
AF:
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
28
56
83
111
139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.